[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352730-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352730-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","loss-of-znrf3rnf43-unleashes-egfr-in-cancer-research-article","Loss of ZNRF3/RNF43 unleashes EGFR in cancer - Research Article","","ZNRF3 and RNF43 are closely related transmembrane E3 ubiquitin ligases central to development and cancer. Conventional views link them to controlling WNT signaling receptor ubiquitination and degradation, but proteogenomic analyses identify EGFR as the protein most negatively correlated with ZNRF3/RNF43 mRNA across multiple human cancers. Biochemical experiments show extracellular-domain interaction that enables ZNRF3/RNF43-driven EGFR ubiquitination and degradation, reducing cancer growth in models. Conversely, ZNRF3/RNF43 loss activates EGFR signaling, promoting tumorigenesis and connecting EGFR and WNT pathways at membrane receptors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/loss-of-znrf3rnf43-unleashes-egfr-in-cancer-research-article/352730/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/loss-of-znrf3rnf43-unleashes-egfr-in-cancer-research-article/352730.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What relationship between ZNRF3/RNF43 and EGFR is proposed in this study?","Question",{"text":63,"@type":64},"The study proposes that loss of ZNRF3 and RNF43 leads to dysregulation of EGFR signaling in cancer, based on evidence that EGFR is negatively correlated with ZNRF3/RNF43 mRNA levels and interacts with them.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do ZNRF3/RNF43 affect EGFR at the molecular level?",{"text":68,"@type":64},"ZNRF3/RNF43 interact with EGFR through their extracellular domains and facilitate EGFR ubiquitination and subsequent degradation via their RING domain.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the functional effects of ZNRF3/RNF43 overexpression or knockout?",{"text":72,"@type":64},"Overexpression of ZNRF3 reduces EGFR levels and suppresses cancer cell growth in vitro and in vivo, while knockout or loss of ZNRF3/RNF43 stimulates cell growth and tumorigenesis through increased EGFR signaling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352730,1790153294,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","RESEARCH ARTICLE  \n*For correspondence:  \n[fy2111@nyu.edu](fy2111@nyu.edu) (FY); [liyi@bcm.edu](liyi@bcm.edu) (YL)  \nCompeting interest: The authors declare that no competing interests exist.  \nFunding: See page 20  \nSent for Review  \n04 January 2024  \nPreprint posted  \n11 January 2024  \nReviewed preprint posted  \n19 March 2024  \nReviewed preprint revised  \n17 February 2025  \nVersion of Record published  \n10 April 2026  \nReviewing Editor: Roel Nusse, Stanford University, United States  \n Copyright Yue et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use andredistribution provided that the original author and source are credited.  \nLoss of ZNRF3/RNF43 unleashes EGFR in cancer  \nFei Yue1,2*, Amy T Ku1, Payton D Stevens3,4, Megan N Michalski3, Weiyu Jiang1, Jianghua Tu5, Zhongcheng Shi6, Yongchao Dou1, Yi Wang7, Xin-Hua Feng8, Galen Hostetter9, Xiangwei Wu10, Shixia Huang6,11,12,13, Noah F Shroyer2,13, Bing Zhang1,13,14, Bart O Williams3,9, Qingyun Liu5, Xia Lin15, Yi Li1,11,13,16*  \n1 Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, United States; 2 Department of Medicine, Baylor College of Medicine, Houston, United States; 3 Department of Cell Biology, Van Andel Institute, Grand Rapids, United States; 4 Biological Sciences Department, Miami University, Oxford, United States; 5Texas Therapeutics Institute and Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, United States; 6Advanced Technology Cores, Baylor College of Medicine, Houston, United States; 7State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China; 8 Life Sciences Institute, Zhejiang University, Hangzhou, China; 9Van Andel Institute, Core Technologies and Services, Grand Rapids, United States; 10 Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, United States; 11 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; 12 Department of Education, Innovation and Technology, Baylor College of Medicine, Houston, United States; 13 Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States; 14 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States; 15The First Affiliated Hospital of Zhejiang University, Hangzhou, China; 16 Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States  \neLife Assessment  \nThis manuscript presents solid evidence suggesting that the loss of ZNRF3 and RNF43, two E3 ubiquitin ligases, leads to dysregulation of EGFR signaling in cancer. The authors propose that EGFR is a direct substrate of ZNRF3/RNF43 . While the authors provide immunoprecipitation data showing increased detection of ubiquitinated species, this evidence does not definitively establish that EGFR itself is ubiquitinated by RNF43/ZNRF3 . The absence of direct evidence for EGFR ubiquitination is a major limitation, although the findings are useful as they may provide novel insights into the mechanisms underlying EGFR-driven cancers and open new therapeutic avenues.  \nAbstract ZNRF3 and RNF43 are closely related transmembrane E3 ubiquitin ligases with significant roles in development and cancer. Conventionally, their biological functions have been associated with regulating WNT signaling receptor ubiquitination and degradation. However, our proteogenomic studies have revealed EGFR as the protein most negatively correlated with ZNRF3/ RNF43 mRNA levels in multiple human cancers. Through biochemical investigations, we demonstrate that ZNRF3/RNF43 interact with EGFR via their extracellular domains, leading to EGFR  \nYue et al. eLife 2024;13:RP95639. DOI: [https://doi.org/10.7554/eLife.95639](https://doi.org/10.7554/eL","cbCaicl3P8eXlzTx","https://ap.wps.com/l/cbCaicl3P8eXlzTx","pdf",5890686,25,"English","# eLife Assessment\n# Abstract\n# Introduction","[{\"question\":\"What relationship between ZNRF3/RNF43 and EGFR is proposed in this study?\",\"answer\":\"The study proposes that loss of ZNRF3 and RNF43 leads to dysregulation of EGFR signaling in cancer, based on evidence that EGFR is negatively correlated with ZNRF3/RNF43 mRNA levels and interacts with them.\"},{\"question\":\"How do ZNRF3/RNF43 affect EGFR at the molecular level?\",\"answer\":\"ZNRF3/RNF43 interact with EGFR through their extracellular domains and facilitate EGFR ubiquitination and subsequent degradation via their RING domain.\"},{\"question\":\"What are the functional effects of ZNRF3/RNF43 overexpression or knockout?\",\"answer\":\"Overexpression of ZNRF3 reduces EGFR levels and suppresses cancer cell growth in vitro and in vivo, while knockout or loss of ZNRF3/RNF43 stimulates cell growth and tumorigenesis through increased EGFR signaling.\"}]","Loss of ZNRF3/RNF43 unleashes EGFR in cancer - Research Article | PDF",1790101146,63,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3b30dcc4fe8c97603974f5bcacfc488.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ab724657e16660c08d99bd25e9ad846.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4573de435823421ca35f626ce4438735.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07f51640387413a65ce5635d1d8c3a0a.webp",980,1268]